Piqray 50 MG Oral Tablet
- RxCUI
- 2169318
- RxNorm name
- Piqray 50 MG Oral Tablet
- Display name
- Piqray 50 MG Oral Tablet
- Full name
- Piqray 50 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PIQRAY | ALPELISIB | Novartis Pharmaceuticals Corporation | b20b4e18-7a4b-4500-a08f-06c6dab0ee5b | 2025-12-15 | Warnings, Adverse reactions | 2169318 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b20b4e18-7a4b-4500-a08f-06c6dab0ee5b | Piqray 50 MG Oral Tablet | SY | 13 | These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY ® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019 | 20251215 |
| b20b4e18-7a4b-4500-a08f-06c6dab0ee5b | alpelisib 50 MG Oral Tablet [Piqray] | SBD | 13 | These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY ® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019 | 20251215 |
| b20b4e18-7a4b-4500-a08f-06c6dab0ee5b | PIQRAY 50 MG Oral Tablet | PSN | 13 | These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY ® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019 | 20251215 |